210 related articles for article (PubMed ID: 30843133)
21. Lymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: a population-based study using the National Cancer Institute SEER database.
Clark CJ; Wood-Wentz CM; Reid-Lombardo KM; Kendrick ML; Huebner M; Que FG
HPB (Oxford); 2011 Sep; 13(9):612-20. PubMed ID: 21843261
[TBL] [Abstract][Full Text] [Related]
22. Prognostic values of tissue-resident CD8
Chen L; Huang H; Huang Z; Chen J; Liu Y; Wu Y; Li A; Ge J; Fang Z; Xu B; Zheng X; Wu C
World J Surg Oncol; 2023 Apr; 21(1):124. PubMed ID: 37024870
[TBL] [Abstract][Full Text] [Related]
23. CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma.
Guo XJ; Lu JC; Zeng HY; Zhou R; Sun QM; Yang GH; Pei YZ; Meng XL; Shen YH; Zhang PF; Cai JB; Huang PX; Ke AW; Shi YH; Zhou J; Fan J; Chen Y; Yang LX; Shi GM; Huang XY
Front Immunol; 2021; 12():705378. PubMed ID: 34526987
[TBL] [Abstract][Full Text] [Related]
24. Survival after Resection of Multiple Tumor Foci of Intrahepatic Cholangiocarcinoma.
Buettner S; Ten Cate DWG; Bagante F; Alexandrescu S; Marques HP; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Margonis GA; Weiss M; Bauer TW; Shen F; Poultsides GA; Marsh JW; IJzermans JNM; Pawlik TM; Koerkamp BG
J Gastrointest Surg; 2019 Nov; 23(11):2239-2246. PubMed ID: 30887301
[TBL] [Abstract][Full Text] [Related]
25. Resection of intrahepatic cholangiocarcinoma in elderly patients - is it reasonable?
Bartsch F; Baumgart J; Tripke V; Hoppe-Lotichius M; Heinrich S; Lang H
BMC Surg; 2019 Oct; 19(1):157. PubMed ID: 31664988
[TBL] [Abstract][Full Text] [Related]
26. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.
Tamandl D; Herberger B; Gruenberger B; Puhalla H; Klinger M; Gruenberger T
Ann Surg Oncol; 2008 Oct; 15(10):2787-94. PubMed ID: 18685896
[TBL] [Abstract][Full Text] [Related]
27. [Cholangiocellular cancer: the state of the problem and ways to improve the results of surgical treatment].
Patyutko YI; Polyakov AN; Podluzhnyi DV; Syskova AY; Sagaidak IV; Kotel'nikov AG; Sergeeva ON; Pokataev IA
Khirurgiia (Mosk); 2018; (12):30-37. PubMed ID: 30560842
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of repeat surgery for recurrence after primary hepatectomy in patients with intrahepatic cholangiocarcinoma.
Tokuda K; Morine Y; Saito Y; Yamada S; Miyazaki K; Yamashita S; Okikawa S; Ikemoto T; Imura S; Shimada M
Int J Clin Oncol; 2020 Dec; 25(12):2083-2089. PubMed ID: 32869120
[TBL] [Abstract][Full Text] [Related]
29. The Prognostic Prediction Role of Preoperative Serum Albumin Level in Patients with Intahepatic Cholangiocarcinoma Following Hepatectomy.
Shen J; Wen T; Li C; Yan L; Li B; Yang J
Dig Dis; 2018; 36(4):306-313. PubMed ID: 29672305
[TBL] [Abstract][Full Text] [Related]
30. Long-term results of surgical treatment of intrahepatic cholangiocarcinoma.
Gurmikov BN; Vishnevsky VA; Kovalenko YA; Chzhao AV
Khirurgiia (Mosk); 2020; (5):5-11. PubMed ID: 32500683
[TBL] [Abstract][Full Text] [Related]
31. Long-term survival of patients with cholangiolocellular carcinoma after curative hepatectomy.
Ariizumi S; Kotera Y; Katagiri S; Nakano M; Nakanuma Y; Saito A; Yamamoto M
Ann Surg Oncol; 2014 Jun; 21 Suppl 3(Suppl 3):S451-8. PubMed ID: 24633664
[TBL] [Abstract][Full Text] [Related]
32. [Surgical therapy of intrahepatic cholangiocellular carcinoma].
Lang H; Sotiropoulos GC; Brokalaki E; Frühauf NR; Radü J; Paul A; Wohlschlaeger J; Baba HA; Malagó M; Broelsch CE
Chirurg; 2006 Jan; 77(1):53-60. PubMed ID: 16170505
[TBL] [Abstract][Full Text] [Related]
33. The elevated preoperative neutrophil-to-lymphocyte ratio predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy.
Chen Q; Yang LX; Li XD; Yin D; Shi SM; Chen EB; Yu L; Zhou ZJ; Zhou SL; Shi YH; Fan J; Zhou J; Dai Z
Tumour Biol; 2015 Jul; 36(7):5283-9. PubMed ID: 25672606
[TBL] [Abstract][Full Text] [Related]
34. Conditional Probability of Long-term Survival After Liver Resection for Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 535 Patients.
Spolverato G; Kim Y; Ejaz A; Alexandrescu S; Marques H; Aldrighetti L; Gamblin TC; Pulitano C; Bauer TW; Shen F; Sandroussi C; Poultsides G; Maithel SK; Pawlik TM
JAMA Surg; 2015 Jun; 150(6):538-45. PubMed ID: 25831462
[TBL] [Abstract][Full Text] [Related]
35. Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery.
Miwa S; Miyagawa S; Kobayashi A; Akahane Y; Nakata T; Mihara M; Kusama K; Soeda J; Ogawa S
J Gastroenterol; 2006 Sep; 41(9):893-900. PubMed ID: 17048054
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of MUC4 for mass-forming intrahepatic cholangiocarcinoma after hepatectomy.
Yeh CN; Pang ST; Wu RC; Chen TW; Jan YY; Chen MF
Oncol Rep; 2009 Jan; 21(1):49-56. PubMed ID: 19082442
[TBL] [Abstract][Full Text] [Related]
37. Visceral infiltration of intrahepatic cholangiocarcinoma is most prognostic after curative resection - Retrospective cohort study of 102 consecutive liver resections from a single center.
Bartsch F; Baumgart J; Hoppe-Lotichius M; Schmidtmann I; Heinrich S; Lang H
Int J Surg; 2018 Jul; 55():193-200. PubMed ID: 29803768
[TBL] [Abstract][Full Text] [Related]
38. Is Hepatic Resection for Large or Multifocal Intrahepatic Cholangiocarcinoma Justified? Results from a Multi-Institutional Collaboration.
Spolverato G; Kim Y; Alexandrescu S; Popescu I; Marques HP; Aldrighetti L; Clark Gamblin T; Miura J; Maithel SK; Squires MH; Pulitano C; Sandroussi C; Mentha G; Bauer TW; Newhook T; Shen F; Poultsides GA; Wallis Marsh J; Pawlik TM
Ann Surg Oncol; 2015 Jul; 22(7):2218-25. PubMed ID: 25354576
[TBL] [Abstract][Full Text] [Related]
39. Impact of Morphological Status on Long-Term Outcome Among Patients Undergoing Liver Surgery for Intrahepatic Cholangiocarcinoma.
Bagante F; Spolverato G; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Itaru E; Pawlik TM
Ann Surg Oncol; 2017 Sep; 24(9):2491-2501. PubMed ID: 28466403
[TBL] [Abstract][Full Text] [Related]
40. Surgery for periductal infiltrating type intrahepatic cholangiocarcinoma without hilar invasion provides a better outcome than for mass-forming type intrahepatic cholangiocarcinoma without hilar invasion.
Imai K; Yamamoto M; Ariizumi S
Hepatogastroenterology; 2010; 57(104):1333-6. PubMed ID: 21443080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
